Uptake and metabolism of cisplatin by rat kidney

R. Safirstein, P. Miller, Joseph Guttenplan

Research output: Contribution to journalArticle

Abstract

Cisplatin, an effective antineoplastic agent, is toxic to the kidney. Since the kidney's vulnerability to cisplatin may originate in its ability to accumulate and retain platinum to a greater degree than other organs, we studied the characteristics of the renal accumulation of platinum and investigated the nature of intracellular platinum. Cisplatin and ethylenediammine-dichloroplatinum, nephrotoxic and antineoplastic liganded platinum compounds, were concentrated in rat renal cortical slices fivefold above medium concentration. Platinum uptake was energy- and temperature-dependent and could be inhibited by drugs which inhibit base transport. The organic anions para-aminohippurate and pyrazinoate did not reduce renal slice platinum uptake. Unbound platinum in the blood and urine was predominantly cisplatin but unbound platinum in kidney cytosol was not. This latter compound, in contrast to cisplatin, was not active as a mutagen. These studies suggest that the kidney accumulates platinum in part by transport or specific binding to the base transport system in the kidney and biotransforms it intracellularly. Unbound platinum in the cell is not cisplatin and may no longer be toxic.

Original languageEnglish (US)
Pages (from-to)753-758
Number of pages6
JournalKidney International
Volume25
Issue number5
StatePublished - 1984

Fingerprint

Platinum
Cisplatin
Kidney
Poisons
Antineoplastic Agents
Platinum Compounds
Mutagens
Cytosol
Anions
Urine
Temperature
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Nephrology

Cite this

Uptake and metabolism of cisplatin by rat kidney. / Safirstein, R.; Miller, P.; Guttenplan, Joseph.

In: Kidney International, Vol. 25, No. 5, 1984, p. 753-758.

Research output: Contribution to journalArticle

Safirstein, R, Miller, P & Guttenplan, J 1984, 'Uptake and metabolism of cisplatin by rat kidney', Kidney International, vol. 25, no. 5, pp. 753-758.
Safirstein, R. ; Miller, P. ; Guttenplan, Joseph. / Uptake and metabolism of cisplatin by rat kidney. In: Kidney International. 1984 ; Vol. 25, No. 5. pp. 753-758.
@article{be49fd3ed4964392959cf40325cef4b7,
title = "Uptake and metabolism of cisplatin by rat kidney",
abstract = "Cisplatin, an effective antineoplastic agent, is toxic to the kidney. Since the kidney's vulnerability to cisplatin may originate in its ability to accumulate and retain platinum to a greater degree than other organs, we studied the characteristics of the renal accumulation of platinum and investigated the nature of intracellular platinum. Cisplatin and ethylenediammine-dichloroplatinum, nephrotoxic and antineoplastic liganded platinum compounds, were concentrated in rat renal cortical slices fivefold above medium concentration. Platinum uptake was energy- and temperature-dependent and could be inhibited by drugs which inhibit base transport. The organic anions para-aminohippurate and pyrazinoate did not reduce renal slice platinum uptake. Unbound platinum in the blood and urine was predominantly cisplatin but unbound platinum in kidney cytosol was not. This latter compound, in contrast to cisplatin, was not active as a mutagen. These studies suggest that the kidney accumulates platinum in part by transport or specific binding to the base transport system in the kidney and biotransforms it intracellularly. Unbound platinum in the cell is not cisplatin and may no longer be toxic.",
author = "R. Safirstein and P. Miller and Joseph Guttenplan",
year = "1984",
language = "English (US)",
volume = "25",
pages = "753--758",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "5",

}

TY - JOUR

T1 - Uptake and metabolism of cisplatin by rat kidney

AU - Safirstein, R.

AU - Miller, P.

AU - Guttenplan, Joseph

PY - 1984

Y1 - 1984

N2 - Cisplatin, an effective antineoplastic agent, is toxic to the kidney. Since the kidney's vulnerability to cisplatin may originate in its ability to accumulate and retain platinum to a greater degree than other organs, we studied the characteristics of the renal accumulation of platinum and investigated the nature of intracellular platinum. Cisplatin and ethylenediammine-dichloroplatinum, nephrotoxic and antineoplastic liganded platinum compounds, were concentrated in rat renal cortical slices fivefold above medium concentration. Platinum uptake was energy- and temperature-dependent and could be inhibited by drugs which inhibit base transport. The organic anions para-aminohippurate and pyrazinoate did not reduce renal slice platinum uptake. Unbound platinum in the blood and urine was predominantly cisplatin but unbound platinum in kidney cytosol was not. This latter compound, in contrast to cisplatin, was not active as a mutagen. These studies suggest that the kidney accumulates platinum in part by transport or specific binding to the base transport system in the kidney and biotransforms it intracellularly. Unbound platinum in the cell is not cisplatin and may no longer be toxic.

AB - Cisplatin, an effective antineoplastic agent, is toxic to the kidney. Since the kidney's vulnerability to cisplatin may originate in its ability to accumulate and retain platinum to a greater degree than other organs, we studied the characteristics of the renal accumulation of platinum and investigated the nature of intracellular platinum. Cisplatin and ethylenediammine-dichloroplatinum, nephrotoxic and antineoplastic liganded platinum compounds, were concentrated in rat renal cortical slices fivefold above medium concentration. Platinum uptake was energy- and temperature-dependent and could be inhibited by drugs which inhibit base transport. The organic anions para-aminohippurate and pyrazinoate did not reduce renal slice platinum uptake. Unbound platinum in the blood and urine was predominantly cisplatin but unbound platinum in kidney cytosol was not. This latter compound, in contrast to cisplatin, was not active as a mutagen. These studies suggest that the kidney accumulates platinum in part by transport or specific binding to the base transport system in the kidney and biotransforms it intracellularly. Unbound platinum in the cell is not cisplatin and may no longer be toxic.

UR - http://www.scopus.com/inward/record.url?scp=0021275886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021275886&partnerID=8YFLogxK

M3 - Article

VL - 25

SP - 753

EP - 758

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 5

ER -